Search
for
Sort by
Research 31–60 of 136
- MINOXIDIL IN RESISTANT HYPERTENSION
- Hirsutism
- Tyrosine kinase inhibition and grey hair
- JAK inhibitors and alopecia areata
- JOHNE'S AND CROHN'S
- Acquired perforating dermatosis in renal and diabetic patients
- Reversible ageusia associated with losartan
- AMINOGENIC ALOPECIA LOSS OF HAIR ASSOCIATED WITH ARGININOSUCCINIC ACIDURIA
- Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: A systematic review and meta-analysis
- Idiopathic CD4+ T-lymphocytopenia
- MINOXIDIL FOR MALE-PATTERN BALDNESS
- International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women’s health condition
- PERICARDIAL EFFUSIONS ASSOCIATED WITH MINOXIDIL
- Re-identification of anonymised MRI head images with publicly available software: investigation of the current risk to patient privacy
- Context-dependent effect of sPLA2-IIA induced proliferation on murine hair follicle stem cells and human epithelial cancer
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Centuries of seeking chocolate's medicinal benefits
- ALOPECIA AREATA TREATED WITH THORIUM-X
- Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
- Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma
- A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
- Circadian rhythm sleep-wake disorders (CRSWDs): Linking circadian misalignment to adverse health outcomes.
- An X-traordinary stroke
- Off-label prescriptions: patient safety first
- Angiogenesis and minoxidil
- SALICYLATE INGESTION AND IDIOPATHIC HAIR LOSS
- Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial
- The new regenerative and innovative strategies in hair loss
- Aching alopecia